Foscavir receives new indication
Foscavir receives new indication
The Food and Drug Administration has authorized a new indication for foscarnet sodium (Foscavir) for AIDS-related cytomegalovirus (CMV) retinitis. The indication allows the use of the drug in combination with intravenous ganciclovir (Cytovene) in CMV retinitis patients who have relapsed after an initial course of single treatment with either drug.
Foscavir also may be prescribed as monotherapy for the treatment of AIDS-related CMV retinitis and for the treatment of acyclovir-resistant mucocutaneous herpes simplex virus infections in immunocompromised patients.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.